NCT04192344 2025-05-22A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid TumorAbbisko Therapeutics Co, LtdPhase 1 Recruiting276 enrolled
NCT01804530 2018-08-02Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid TumorsPlexxikonPhase 1 Terminated59 enrolled
NCT02673736 2018-08-02A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell TumorPlexxikonPhase 1 Terminated11 enrolled